ATE13667T1 - 8-aza-16,16-difluor-prostanoide. - Google Patents

8-aza-16,16-difluor-prostanoide.

Info

Publication number
ATE13667T1
ATE13667T1 AT81303641T AT81303641T ATE13667T1 AT E13667 T1 ATE13667 T1 AT E13667T1 AT 81303641 T AT81303641 T AT 81303641T AT 81303641 T AT81303641 T AT 81303641T AT E13667 T1 ATE13667 T1 AT E13667T1
Authority
AT
Austria
Prior art keywords
aza
difluoroprostanoids
stereo
active
prostanoids
Prior art date
Application number
AT81303641T
Other languages
English (en)
Inventor
Richard Merrill Scribner
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Application granted granted Critical
Publication of ATE13667T1 publication Critical patent/ATE13667T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
AT81303641T 1980-08-11 1981-08-10 8-aza-16,16-difluor-prostanoide. ATE13667T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/176,784 US4320136A (en) 1980-08-11 1980-08-11 8-Aza-16,16-difluoroprostanoids
EP81303641A EP0046082B1 (de) 1980-08-11 1981-08-10 8-Aza-16,16-difluor-prostanoide

Publications (1)

Publication Number Publication Date
ATE13667T1 true ATE13667T1 (de) 1985-06-15

Family

ID=22645804

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81303641T ATE13667T1 (de) 1980-08-11 1981-08-10 8-aza-16,16-difluor-prostanoide.

Country Status (7)

Country Link
US (1) US4320136A (de)
EP (1) EP0046082B1 (de)
JP (1) JPS5754166A (de)
AT (1) ATE13667T1 (de)
CA (1) CA1161447A (de)
DE (1) DE3170838D1 (de)
DK (1) DK352281A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530933A (en) * 1982-12-27 1985-07-23 E. I. Du Pont De Nemours And Company 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
US4456613A (en) * 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
NZ525164A (en) * 2000-11-27 2005-04-29 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis
EP1408961B1 (de) * 2001-07-16 2007-07-11 F. Hoffmann-La Roche Ag 2 pyrrolidon-derivate als prostanoid-agonisten
ES2254726T3 (es) 2001-07-16 2006-06-16 F. Hoffmann-La Roche Ag Analogos de prostaglandina como agonistas receptores de ep4.
CN101921220B (zh) 2001-07-23 2013-05-22 小野药品工业株式会社 治疗与骨质损失有关的疾病的含有ep4激动剂作为活性成分的药物组合物
US20040254230A1 (en) * 2001-12-03 2004-12-16 Ogidigben Miller J. Method for treating ocular hypertension
BRPI0406717A (pt) * 2003-01-10 2005-12-20 Hoffmann La Roche Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20080058375A1 (en) * 2004-01-08 2008-03-06 Elworthy Todd R 2-Piperidone derivatives as prostaglandin antagonists
CA2738045C (en) * 2010-05-28 2019-02-19 Simon Fraser University Conjugate compounds, methods of making same, and uses thereof
HUE031885T2 (en) 2012-07-19 2017-08-28 Cayman Chemical Co Inc Difluoro lactam preparations for EP4-mediated osteo-related diseases and conditions
WO2014144500A2 (en) 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
ES2635635T3 (es) 2013-03-15 2017-10-04 Cayman Chemical Company, Incorporated Compuestos de difluorolactama como agonistas selectivos del receptor EP4 para su uso en el tratamiento de enfermedades y afecciones mediadas por EP4
KR20160048054A (ko) 2013-07-19 2016-05-03 카이맨 케미칼 컴파니 인코포레이티드 골 성장의 촉진을 위한 방법, 시스템 및 조성물
US9650414B1 (en) 2014-05-30 2017-05-16 Simon Fraser University Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof
US10400000B2 (en) 2015-06-12 2019-09-03 Simon Fraser University Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873566A (en) * 1973-02-28 1975-03-25 Du Pont 3-Pyrazolidinones and pyrazolidines
US3974189A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin E2 analogs
US3962293A (en) * 1973-07-20 1976-06-08 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin F1
US3969376A (en) * 1973-07-20 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin E1 analogs
US3974191A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin F1 analogs
US3974192A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin B1 analogs
US3974190A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin A1 analogs
US3974193A (en) * 1973-07-20 1976-08-10 The Upjohn Company 16-Fluoro prostaglandin B2 analogs
US3969378A (en) * 1973-07-20 1976-07-13 The Upjohn Company 16-Fluoro prostaglandin A2 analogs
US4187381A (en) * 1973-08-06 1980-02-05 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4017534A (en) * 1974-06-03 1977-04-12 American Cyanamid Company 16-Fluoro-11-deoxy-13-dihydro-prostaglandin
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
US3969381A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin B1 analogs
US3969379A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin A1 analogs
US3969380A (en) * 1975-02-21 1976-07-13 The Upjohn Company 16-Fluoro prostaglandin F2 analogs
US3969377A (en) * 1975-02-21 1976-07-13 The Upjohn Company 16-Fluoro prostaglandin E1 analogs
US4113873A (en) * 1975-04-26 1978-09-12 Tanabe Seiyaku Co. Ltd. 8-azaprostanoic acid derivatives
US4003911A (en) * 1975-09-26 1977-01-18 E. I. Du Pont De Nemours And Company Selected 3-pyrrolidinones and 2,4-pyrrolidindiones
US4032533A (en) * 1976-02-19 1977-06-28 E. I. Du Pont De Nemours And Company 3,4-disubstituted-1,3,4-thiadiazoline-2,5-diones
IL49325A (en) * 1976-03-31 1979-11-30 Labaz 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
DE2619638A1 (de) 1976-05-04 1977-11-17 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
US4177346A (en) * 1976-08-06 1979-12-04 Pfizer Inc. 1,5-Disubstituted-2-pyrrolidones
US4211876A (en) * 1979-06-13 1980-07-08 E. I. Du Pont De Nemours And Company 3-Pyrazolidinone carboxamides

Also Published As

Publication number Publication date
CA1161447A (en) 1984-01-31
EP0046082A2 (de) 1982-02-17
DK352281A (da) 1982-02-12
EP0046082B1 (de) 1985-06-05
EP0046082A3 (en) 1982-03-03
DE3170838D1 (en) 1985-07-11
JPS5754166A (en) 1982-03-31
US4320136A (en) 1982-03-16

Similar Documents

Publication Publication Date Title
DE3170838D1 (en) 8-aza-16,16-difluoroprostanoids
ES8600377A1 (es) Un metodo para preparar una composicion acuosa para limpieza
LU88359I2 (fr) Claritine
DK566784A (da) Substituerede trans-1,2-diaminocyclohexylamidforbindelser
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
FI811485A7 (fi) Pyörösahan rakenne.
NL189272B (nl) Bipolaire transistor.
DE3381898D1 (de) Prostaglandin enthaltende zusammensetzungen.
FI834473A7 (fi) Amidfoereningar.
FI841056L (fi) Triazol-svampbekaempningsmedel.
NO160325C (no) Demonterbar stolfot.
NO152667C (no) Lyddempningsanordning for blandeventil.
NO153993C (no) Baandsag.
BG40952A3 (en) Herbicide means
SU1095611A1 (ru) Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью
ATE41927T1 (de) Phenylalkylamine - bioregulatoren.
TR22871A (tr) Birden fazla aktif bilesen ihtiva eden piretroid terkipleri
FI832241A7 (fi) Antihypertensiivisina aineina käyttökelpoiset substituoidut fenyylipiperatsiiniyhdisteet, ja menetelniiden valmistamiseksi.
ES8801647A1 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas
IT8322393A0 (it) Supporto per albero.
SU1269296A1 (ru) Гербицидный состав
BG42351A3 (bg) Средство за регулиране растежа на растения
SU1131198A1 (ru) 2-Этоксикарбонил-3-бромметил-4,4-диметилбутенолид-2, проявляющий противостафилококковую активность
SU1066155A1 (ru) п-Толилсульфонилгидразиды диарилгликолевых кислот, проявляющие ростстимулирующую активность
SE8207186D0 (sv) Terapeutiskt aktiva, membranstabiliserande medel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee